Cargando…

Early-versus Late-Onset Alzheimer Disease: Long-Term Functional Outcomes, Nursing Home Placement, and Risk Factors for Rate of Progression

BACKGROUND/AIMS: Whether age at onset influences functional deterioration in Alzheimer disease (AD) is unclear. We, therefore, investigated risk factors for progression in activities of daily living (ADL) and nursing home placement (NHP) in cholinesterase inhibitor (ChEI)-treated patients with early...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wattmo, Carina, Wallin, Åsa K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2017
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471791/ https://www.ncbi.nlm.nih.gov/pubmed/28626471 http://dx.doi.org/10.1159/000455943

Ejemplares similares

Early- versus late-onset Alzheimer’s disease in clinical practice: cognitive and global outcomes over 3 years
por: Wattmo, Carina, et al.
Publicado: (2017)

Short-Term Response to Cholinesterase Inhibitors in Alzheimer’s Disease Delays Time to Nursing Home Placement
por: Wattmo, Carina, et al.
Publicado: (2018)

Predictors of long-term cognitive outcome in Alzheimer's disease
por: Wattmo, Carina, et al.
Publicado: (2011)

Galantamine treatment in Alzheimer’s disease: response and long-term outcome in a routine clinical setting
por: Wallin, Åsa K, et al.
Publicado: (2011)

Progression of mild Alzheimer’s disease: knowledge and prediction models required for future treatment strategies
por: Wattmo, Carina, et al.
Publicado: (2013)

Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy
por: Wattmo, Carina, et al.
Publicado: (2016)

Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer’s disease cohort
por: Wattmo, Carina, et al.
Publicado: (2012)

Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application
por: Wattmo, Carina, et al.
Publicado: (2013)

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
por: Wattmo, Carina, et al.
Publicado: (2020)

Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer’s disease: a prospective, observational study of factors affecting survival time from admission to death
por: Wattmo, Carina, et al.
Publicado: (2016)

A longitudinal study of risk factors for community-based home help services in Alzheimer’s disease: the influence of cholinesterase inhibitor therapy
por: Wattmo, Carina, et al.
Publicado: (2013)

High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer’s disease
por: Degerman Gunnarsson, Malin, et al.
Publicado: (2016)

Psychotropic and anti-dementia treatment in elderly persons with clinical signs of dementia with Lewy bodies: a cross-sectional study in 40 nursing homes in Sweden
por: Zahirovic, Iris, et al.
Publicado: (2018)

Survival among the older adults with clinical signs of Lewy body dementia in 40 Swedish nursing homes: a 6-year follow-up study
por: Zahirovic, Iris, et al.
Publicado: (2019)

Similar pattern of atrophy in early- and late-onset Alzheimer's disease
por: Eckerström, Carl, et al.
Publicado: (2018)

Response to cholinesterase inhibitors affects lifespan in Alzheimer’s disease
por: Wattmo, Carina, et al.
Publicado: (2014)

Solitary living in Alzheimer’s disease over 3 years: association between cognitive and functional impairment and community-based services
por: Wattmo, Carina, et al.
Publicado: (2014)

Comorbidity and progression of late onset Alzheimer’s disease: A systematic review
por: Haaksma, Miriam L., et al.
Publicado: (2017)

Hurricane Irma’s Impact on Assisted Living Residents’ Rates of Hospitalization, Nursing Home Placement, and Mortality
por: Hua, Cassandra, et al.
Publicado: (2020)

Clinical characteristics associated with the onset of delirium among long-term nursing home residents
por: Cheung, Evelyn Ning Man, et al.
Publicado: (2018)

Long-Term Clinical and Radiologic Outcomes after Stent-Graft Placement for the Treatment of Late-Onset Post-Pancreaticoduodenectomy Arterial Hemorrhage
Publicado: (2021)

A Quick Test of cognitive speed is sensitive in detecting early treatment response in Alzheimer's disease
por: Palmqvist, Sebastian, et al.
Publicado: (2010)

Predictors of nursing home placement at 2 years in Alzheimer's disease: A follow‐up survey from the THERAD study
por: Villars, Hélène, et al.
Publicado: (2022)

Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease
por: Haberman, Rebecca P., et al.
Publicado: (2017)

Late onset Alzheimer’s disease in older people
por: Isik, Ahmet Turan
Publicado: (2010)

The Clinical Features and Progression of Late-Onset Versus Younger-Onset in an Adult Cohort of Huntington’s Disease Patients
por: Anil, Megha, et al.
Publicado: (2020)

Nursing students’ experience with clinical placement in nursing homes: a focus group study
por: Laugaland, Kristin, et al.
Publicado: (2021)

The influence of caregivers and behavioral and psychological symptoms on nursing home placement of persons with Alzheimer’s disease: A matched case–control study
por: Porter, Candace N, et al.
Publicado: (2016)

Cerebral inflammation is an underlying mechanism of early death in Alzheimer’s disease: a 13-year cause-specific multivariate mortality study
por: Nägga, Katarina, et al.
Publicado: (2014)

Heart rate variability and baroreceptor reflex sensitivity in early- versus late-onset preeclampsia
por: Weber, Thomas Michael, et al.
Publicado: (2017)

Late Onset Uveitis-glaucoma-hyphema Syndrome with Out-the-bag Placement of Intraocular Lens
por: Zhou, Benjamin, et al.
Publicado: (2022)

Neonatal Septicemia in Nepal: Early-Onset versus Late-Onset
por: Ansari, Shamshul, et al.
Publicado: (2015)

Early and late-onset Alzheimer's disease: What are the differences?
por: Awada, Adnan A.
Publicado: (2015)

Poor self-rated health did not increase risk of permanent nursing placement or mortality in people with mild Alzheimer’s disease
por: Nielsen, Anni Brit Sternhagen, et al.
Publicado: (2016)

Radiomic Features of the Hippocampus for Diagnosing Early-Onset and Late-Onset Alzheimer’s Disease
por: Du, Yang, et al.
Publicado: (2022)

Early‐onset Alzheimer's disease explained by polygenic risk of late‐onset disease?
por: Mantyh, William G., et al.
Publicado: (2023)

Kickstart in nursing home—Nursing students experiences of a model for active and collaborative learning in clinical placement
por: Tveit, Bodil, et al.
Publicado: (2023)

Work Placement and Job Satisfaction in Long-Term Childhood Cancer Survivors: The Impact of Late Effects
por: Dionisi-Vici, Margherita, et al.
Publicado: (2022)

Glucose Metabolic Brain Networks in Early-Onset vs. Late-Onset Alzheimer's Disease
por: Chung, Jinyong, et al.
Publicado: (2016)

Biopharmaceutical Monotargeting versus ‘Universal Targeting’ of Late-Onset Alzheimer’s Disease Using Mixtures of Pleiotropic Natural Compounds
por: Friel, Howard
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gj6mpqev46oion4c1usmsiar3t